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Using risk-tracing snowball approach
to increase HIV case detection among
high-risk populations in Cambodia:
an intervention study
Srean Chhim1,6* , John Macom2, Chettana Pav1, Nirada Nim1, Phearun Yun3, Sopheap Seng1, Kolab Chhim4,
Sovannary Tuot4 and Siyan Yi4,5

Abstract
Background: Early HIV diagnosis and initiation onto antiretroviral therapy may prevent ongoing spread of HIV. Risk
Tracing Snowball Approach (RTSA) has been shown to be effective in detecting new HIV cases in other settings.
The main objective of this study is to evaluate the effectiveness of RTSA in increasing the rate of newly identified
HIV cases among high-risk populations. Our second objective was to evaluate the effectiveness of RTSA, as
compared to the walk-in group, in increasing the number of HIV tests and early case detection.
Methods: This study was conducted from April 1 to September 30, 2016 at two NGO clinics in Phnom Penh, Cambodia.
Respondent driven sampling method was adapted to develop RTSA to reach high-risk populations, including key
populations and the general population who have social connections with key populations. Bivariate and multivariate
logistic regression analyses were conducted.
Results: During the implementation period, 721 clients walked in for HIV testing (walk-in group), and all were invited to
be seeds. Of the invited clients, 36.6% agreed to serve as seeds. Throughout the implementation, 6195 coupons were
distributed to seeds or recruiters, and resulted in 1572 clients visiting the two clinics with coupons (RTSA group), for a
coupon return rate of 25.3%. The rate of newly identified HIV cases among the RTSA group was significantly lower
compared to that in walk-in group. However, the highest number of newly identified HIV cases was found during the
implementation period, compared to both pre- and post-implementation period. Although statistically not significant, the
mean CD4 count of newly identified HIV cases detected through RTSA was almost 200 cells/mm3 higher than that in the
walk-in group.
Conclusions: Although the rate of newly identified HIV cases among the RTSA group was lower than that in the walk-in
group, the inclusion of RTSA in addition to the traditional walk-in method boosted new HIV case detection in the two
participating clinics. A higher mean CD4 count for the RTSA group may reveal that RTSA may be able to detect HIV cases
earlier than the traditional walk-in approach. Further research is needed to understand whether RTSA is a cost-effective
intervention to prevent ongoing spread of the HIV among high-risk populations in Cambodia.
Keywords: HIV, Risk-tracing snowball approach, Key population, New case detection, Intervention study, Cambodia
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Background
Over the past two decades, Cambodia has been successful
in its fight to slow the spread of HIV [1]. HIV prevalence
among the general population decreased from an estimated
1.6% in 1998 to 0.6% in 2015 [2, 3]. The estimated number
of new HIV cases per year also decreased from roughly
4400 in 2005 to 700 in 2015 [2, 3]. Despite this success, as
of 2015, an estimated 74,000 Cambodians were living with
the virus [4]; with about 27% of these individuals (~19,000)
being unaware of their HIV-positive status [2].
Early HIV diagnosis and initiation onto antiretroviral therapy (ART) may prevent ongoing spread of
HIV. Knowledge of one’s HIV-positive status has been
shown to be associated with increased condom use
[5]. ART initiation, when resulting in viral load suppression, can reduce the risk of HIV infection between 89% to 96% to uninfected sexual partners of an
HIV positive individual [6–10].
The Government of Cambodia has committed to
ending the AIDS epidemic by 2020 [3]. It means, by
the year 2020, the annual number of new HIV infections must fall below 300 [3]. To successfully reduce
the number of new HIV infections, innovative approaches are needed to reach people living with HIV
who are unaware of their HIV status and link them
to early diagnosis and treatment. One such approach,
the Risk Tracing Snowball Approach (RTSA) has been
shown to be effective in detecting new HIV cases that
would otherwise not have been found [11–13]. RTSA
is an adaptation of the Respondent Driven Sampling
method, a form of sampling often used in bio-behavioural
surveillance studies, in which study recruitment relies on
peer-referrals [14]. RTSA, which is also sometimes
referred to as a “Peer-Driven Intervention,” has been successfully used to increase the rate of newly undiagnosed
HIV infected individuals among high-risk heterosexuals in
the US [13]. It has also been found to be an effective
approach to rapidly identify newly undiagnosed HIV
individuals among people who use and inject drugs in
Greece [12] and among heterosexual couples in China [11].
However, it has never been implemented in Cambodia
context.
The main objective of this study was to evaluate the
effectiveness of RTSA in increasing the rate of newly
identified HIV cases among high-risk populations, including female entertainment workers (FEW), men who
have sex with men (MSM), transgender (TG) women,
people who inject drugs (PWID), people who use drugs
(PWUD), and the general population who have social
connections to key populations. The second objective
was to evaluate the effectiveness of RTSA, as compared
to the walk-in group, in increasing the number of HIV
tests and early HIV case detection by comparing CD4
count between clients from the two groups.
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Methods
Study settings

The RTSA was implemented between April 1 and
September 30, 2016 at two clinics, Chhouk Sar I and
Chhouk Sar II, in the capital city of Phnom Penh. The
two clinics are operated by the Chhouk Sar Association,
a non-governmental organization (NGO) established in
2010. These two clinics provide comprehensive HIV and
sexual and reproductive health services, including HIV
testing and counselling, ART, as well as sexually transmitted infection (STI) screening and treatment for key
populations— FEW, MSM, TG women, PWID, and
PWUD. These clinics also provide HIV testing services,
but not ART, to the general population. Newly identified
HIV positive individuals from the general population are
referred to a governmental ART site.
Intervention

The RTSA was designed by the HIV/AIDS Flagship
Project [15, 16] to reach high-risk populations. We hypothesized that this intervention would increase the
number of HIV tests and early HIV case detection. All
clients who presented for HIV testing and counselling
services at one of the two clinics were given the
opportunity to serve as “seeds” and recruit other highrisk individuals within their personal social and sexual
networks to get tested for HIV. Seeds were supplied with
five coupons for use in recruiting up to five individuals
from their networks. If a recruited individual (or socalled “recruit”) presented at either clinic with a valid
coupon and screened as being “at risk” for HIV infection
and completed HIV testing, the initial seed who
recruited this individual would receive a financial incentive (2.5 USD). Recruits who received HIV testing and a
risk assessment interview also received the same financial incentive (2.5 USD). Recruits were then offered the
same opportunity as the initial seeds to recruit other
high-risk peers within their social and sexual networks to get tested for HIV. This procedure was applied to all recruits, regardless of wave length, up
until September 30, 2016.
Target populations and inclusion criteria

The goal of RTSA was to reach populations at higher
risk of HIV infection, but less frequently tested for HIV.
This intervention included all clients presenting for HIV
testing at the two selected clinics who (1) were at least
18 years old, (2) had not been tested for HIV anywhere
during the previous 3 months, and (3) provided verbal
informed consent which included being finger printed.
They can be a FEW, MSM, TG women, PWID, PWUD,
and the general population who have social connections
to those key populations.
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Implementation procedures

The RTSA was built on the existing system in place at both
Chhouk Sar clinics. All procedures for voluntary confidential counselling and testing (VCCT) were followed, except
two more activities added to the RTSA. These two activities
are described in Table 1.
To receive the financial incentive associated with successful referrals, some seeds/recruiters presented at the
clinics with the recruited individuals, while others called
coupon managers to check whether their referral was a
success.
It should be noted that the online fingerprint system,
as mentioned in step 3b in Table 1, was an important
tool to ensure that clients could not get tested for HIV
more than once within a three-month period. A
counsellor-administered, tablet-based questionnaire was
built using the Qualtrics application. The application
automatically generated the level of risk for HIV infection at the end of the interview. Clients could reject being registered into the fingerprint system or the
Table 1 Process of RTSA implementation
Steps

Type of activities
Routine clinic Additional
processes
steps for RTSA

Step 1: Clients arrived at Chhouk Sar
clinic, greeted by a receptionist,
and asked about services
needed.

Yes

Step 2: Clients presented for HIV testing
were referred to the VCCT floor,
where they received a queue
number.

Yes

Step 3a: Clients met with a counsellor
for HIV pre-testing counselling.

Yes
Yes

Yes

Step 5: Clients received HIV post-testing Yes
counselling. If HIV-positive, they
were asked to immediately enroll
into Pre-ART/ART treatment at
the clinics if they self-identified
as a key population. Those
self-identified as the general
population were referred to
other Pre-ART/ART sites.
Step 6: Clients met with coupon
manager if they agreed to be
part of RTSA. Coupon manager
explained to seeds/recruiters
on how to use the coupons and
the benefits for referring.

Questionnaire development and measures

The “risk screening tool” questionnaire was initially developed by a technical working group led by the
National Centre for HIV/AIDS Dermatology and STD
(NCHADS) and included key stakeholders in Cambodia.
It was developed to screen for HIV risk behaviors of key
populations. This study used this risk screening tool to
identify individuals at risk for HIV infection.
The main outcome of interest in this study was the
rate of newly identified HIV positive cases. In addition,
there were three other exploratory secondary outcomes,
including the absolute number of HIV tests conducted,
the absolute number of newly-identified HIV positive
cases, and CD4 count for those individuals tested HIV
positive.
The risk assessment tool included questions used to
determine key populations (FEW, MSM, TG women,
PWUD, PWID) categorization, sexual behaviors with
different types of sexual partners since last HIV test, or
lifetime number of sexual partners if not previously been
tested for HIV. Information was also collected on the
history of STI symptoms, illicit drug use, hormone injection for TG women, and pregnancy and abortion for
women.
Data analyses

Step 3b: Clients who consented were
registered, fingerprinted, and
then interviewed using a
tablet-based questionnaire.
Step 4: Clients were tested for
HIV—Determine Test, Stat-Pak,
and Uni-Gold [21].

interview. While they could still be tested for HIV, they
were not part of the RTSA study.

The rate of newly identified HIV positive cases was calculated by dividing the total number of newly identified
HIV positive individuals by the total number of individuals tested for HIV during the implementation period.
Chi-square test, or Fisher’s exact test when a cell count
was smaller than five, were used to describe and compare characteristics between the walk-in group and the
RTSA group. Factors associated with the rate of newly
identified HIV positive cases were explored separately
among the walk-in group and RTSA group. Bivariate
and multivariable logistic regression analyses were
conducted. All variables associated with HIV infection at
a level of p < 0.25 in bivariate analyses were included in
the multivariable models. STATA Version 14.1 for
Windows (Stata Corp, TX, USA) was used to conduct
the data analyses.
Ethical consideration

Yes

Abbreviation: RTSA risk tracking snowball approach, VCCT voluntary
confidential counselling and Testing

This study was approved by the National Ethics Committee
for Health Research (No.085 NECHR) of Ministry of Health
in Cambodia and the FHI 360’s Protection of Human Subjects Committee (No. 590334 PHSC). All participants provided a verbal informed consent, ensuring that they
understood about the voluntary and confidential participation in the study.
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Results
Recruitment flow

As shown in Table 2, over a period of 6 months, between April 1 and September 30, 2016, a total of 721 individuals presented at the two Chouk Sar Clinics for
HIV testing and counselling services. These clients were
invited to serve as ‘seeds’ and recruit high-risk individuals
in their social network. A total of 264 clients (36.6% of
walk-in clients) agreed to serve as seeds. Approximately,
26.1% of the seeds were successful in recruiting at least
one other individual within the 6 months of RTSA implementation. Of 69 networks, which seeds could refer other
peers, the median number of clients per social network
was six (IQR 3-9). The maximum number of clients from
one network was 561 clients. During the six-month implementation, a total of 6195 coupons were distributed to
seeds and recruiters; of which 1572 coupons were
returned, for a coupon-return rate of 25.3%.

illicit drugs since last HIV testing or lifetime if never been
tested for HIV (5.8% vs. 2.2%, p < 0.001).
RTSA clients were significantly less likely to have ever
been previously tested for HIV (58.9% vs. 72.7%,
p < 0.001) and more likely to have had STI symptoms
since last HIV testing or lifetime if never been tested for
HIV (29.5% vs. 55.2%, p < 0.001).
Study outcomes
Number of HIV tests

During the 6 months of RTSA implementation, a total
of 721 walk-in clients and 1572 RTSA clients were tested
for HIV (Fig. 1). The total number of individuals
tested during the RTSA implementation (n = 2293)
represents a 340% increase in the number of tests
from the 6 months prior to the RTSA implementation
(n = 673) and a 271% increase in the number of tests
compared to the 6 months after RTSA implementation ended (n = 845).

Participants’ characteristics

Rate of newly identified HIV positive cases

Table 3 compares key socio-demographic characteristics
of walk-in clients with those of the RTSA group. RTSA
clients were significantly more likely to be male (64.5% vs.
42.4%, <0.001) and PWUD (37.7% vs. 5.6%, p < 0.001)
compared with walk-in clients. Furthermore, RTSA clients
were significantly more likely to have had a commercial
sex partner since last HIV testing or lifetime if never been
tested for HIV (46.4% vs. 31.5%, %, p < 0.001), had sex
without condoms with commercial sex partners since last
HIV testing or lifetime if never been tested for HIV
(26.6% vs. 20.2%, p < 0.001), had 2 or more commercial
sex partners per week since last HIV testing or lifetime if
never been tested for HIV (27.1% vs. 15.3%, %, p < 0.001),
used illicit drugs since last HIV testing or lifetime if never
tested for HIV (57.7% vs. 9.5%, p < 0.001), and injected

As shown in Fig. 2, the rate of newly identified HIV
positive cases was significantly lower among RTSA
clients than that of walk-in clients during the same time
frame (1.8% vs. 3.2%, p = 0.0445), for an odd ratio (OR)
at 0.6 (95% confidence interval (CI), 0.3-0.9). Furthermore, the HIV-positive rate among RTSA was significantly lower compared to that in the 6 months prior to
the RTSA implementation (1.8% vs. 4.8%, p < 0.001), for
an OR at 0.4 (95% CI, 0.2-0.6) and 6 months after the
RTSA implementation (1.8% vs. 3.7%, p = 0.006), for an
OR at 0.5 (95% CI, 0.3-0.8).

Table 2 Summary of recruitment flow
Number

%

Period

Six months
(Apr 1 2016- Sep 30 2016)

Clients walked in for HIV testing
(walk-in group)

721

NA

Clients invited to be seeds

721/721

100.0

Clients agreed to be seeds

264/721

36.6

Seeds referred at least one peer

69/264

26.1

Clients per network (for 69
successful seeds)
Median (IQR)

6 (3-9)

NA

Range

2-561

NA

Coupons distributed

6195

NA

Coupons returned (RTSA group)

1570/6195

25.3

Abbreviations: IQR interquartile range

Number of newly identified HIV positive cases

Despite the lower rate of newly identified HIV positive cases among RTSA group, the highest number of
newly identified HIV positive cases was found during
the RTSA implementation period compared to that in
the 6 months prior to and 6 months after the RTSA
implementation. While only 32 positive cases were
found within the 6 months prior to the RTSA implementation and 31 cases in the 6 months after the
RTSA implementation, a total of 52 cases were found
during the 6 months of the RTSA implementation
(Fig. 3).
CD4 count

CD4 test results were available for only 28 out of 52
newly HIV diagnosed individuals (11 from the RTSA
group and 17 from the walk-in group). Although not statistically significant, the mean CD4 count of newly identified HIV positive cases in the RTSA group was almost
200 cells/mm3 higher than that among those in the
walk-in group (540 ± 271 vs. 355 ± 350).
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Table 3 HIV testing history and risky behaviours (time framea)
Walk-in group
(N = 609b)

RTSA group
(N = 1570b)

n (%)

n (%)

Table 3 HIV testing history and risky behaviours (time framea)
(Continued)

P-value

Biological sex of participants
Male

272 (42.4)

1014 (64.5)

Female

370 (57.6)

558 (35.5)

<0.001

Type of population
<0.001

Walk-in group
(N = 609b)

RTSA group
(N = 1570b)

n (%)

n (%)

Yes

13 (2.2)

91 (5.8)

No

587 (97.8)

1479 (94.2)

FEW

112 (18.4)

313 (19.9)

MSM

29 (4.8)

138 (8.8)

TG women

62 (10.1)

105 (6.7)

Yes

11 (18.0)

9 (8.6)

PWUD

34 (5.6)

593 (37.7)

No

50 (82.0)

96 (91.4)

PWID

7 (1.2)

76 (4.8)

General population

365 (59.9)

345 (21.9)

No

443 (72.7)

925 (58.9)

166 (27.3)

645 (41.1)

Yes

582 (95.6)

1498 (95.4)

No

27 (4.4)

72 (4.6)

<0.001

Ever had sex in lifetime
1.000

Ever had non-commercial partner since last HIV testing or lifetime if
never tested for HIV
Yes

468 (76.8)

1285 (81.8)

No

141 (23.2)

285 (18.2)

<0.001

Sex without a condom with non-commercial partner(s) since last HIV
testing or lifetime if never tested for HIV
Yes

442 (72.6)

1184 (75.4)

No

167 (27.4)

386 (24.6)

0.188

Sex with commercial partner(s) since last HIV testing or lifetime if never
tested for HIV
Yes

192 (31.5)

729 (46.4)

No

417 (68.5)

841 (53.6)

<0.001

Sex without a condom with commercial partner(s) since last HIV testing
or lifetime if never tested for HIV
Yes

123 (20.2)

417 (26.6)

No

486 (79.8)

1153 (73.4)

0.002

Had two or more commercial partners/week since last HIV testing or
lifetime if never tested for HIV
Yes

93 (15.3)

426 (27.1)

No

516 (84.7)

1144 (72.9)

<0.001

Ever had STI symptoms since last HIV testing or lifetime if never tested
for HIV
Yes

336 (55.2)

463 (29.5)

No

273 (44.8)

1107 (70.5)

<0.001

Ever used drugs since last HIV testing or lifetime if never tested for HIV
Yes

57 (9.5)

906 (57.7)

No

543 (90.5)

664 (42.3)

<0.001

Injected hormones/any substances to change your appearance (among
TG women only) since last HIV testing or lifetime if never tested for HIV
0.071

Been pregnant/had a baby/ had an abortion (among women only)
since last HIV testing or lifetime if never tested for HIV

Have been tested for HIV in lifetime
Yes

P-value

Ever injected drugs since last HIV testing or lifetime if never tested
for HIV

<0.001

Yes

31 (31.3)

96 (31.0)

No

77 (68.7)

240 (69.0)

1.000

Abbreviations: FEW female entertainment worker, MSM men who have with
men, TG women transgender women, PWUD people who use drugs, PWID
people who inject drugs
a
Since last HIV testing if they have ever been tested for HIV or lifetime if they
have never been tested for HIV
b
The missing value (n = 112) in the walk-in group and (n = 2) in RTSA group
were excluded from the analyses

Recruiters of newly identified HIV positives

As shown in Table 4, HIV-negative clients recruited a
total of 1532 clients (out of 1572 clients in RTSA). The
rate of newly identified HIV positive cases among those
who were recruited by HIV negative clients was 1.8%.
Clients who were already aware of their HIV-positive
status recruited 19 clients and generated 5.2% rate of
newly identified HIV positive cases. However, clients
who were newly identified as HIV positive recruited 21
clients, but never recruited other newly identified HIV
positive clients.
Translated from Table 4 above, we visualized the
network in a graph as shown in Fig. 4 for a better understanding of how the networks were formed. Red nodes
represent newly identified HIV clients; green nodes represent HIV-negative clients; and blue nodes represent
clients who were already aware of their HIV-positive
status. In most cases, recruitment stops when a client is
newly identified as HIV positive.

Factors associated with HIV infection

Table 5 shows the rate of newly identified HIV positive
cases and its unadjusted associated factors for the walkin group and RTSA group, separately.
In the walk-in group, using the general population as
the reference group, the rate of newly identified HIV
positive cases was significantly higher among MSM (unadjusted OR 8.7, 95% CI 1.4, 54.5), and TG women (unadjusted OR 10.4, 95% CI 2.4, 44.5).

Chhim et al. BMC Infectious Diseases (2017) 17:689
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Fig. 1 Number of individuals tested for HIV. Abbreviations: RTSA, risk tracing snowball approach

In the RTSA group, using the general population as
the reference group, the rate of newly identified HIV
positive cases was significantly higher among FEW (unadjusted OR 3.8, 95% CI 1.0, 13.9). Unlike the walk-in
group, the rate of newly identified HIV positive cases
was not statistically different for MSM and TG women
when compared to the general population, although the
estimated effects were in the same direction.
Table 6 presents the results from multivariable logistic
regression analyses. After adjustment for other variables
in the models, in the walk-in group, a significantly
higher rate of newly identified HIV positive cases was
found among TG women (adjusted OR 15.2, 95% CI 3.1,
75.2), MSM (adjusted OR 10.4, 95% CI 1.4, 77.0), and a
significantly lower rate was found among clients who reported previouly tested for HIV (adjusted OR 0.3, 95%

CI 0.1, 0.9) compared to their comparison group. Unlike
the walk-in group, in the RTSA group, a significantly
higher rate of newly identified HIV positive cases was
found among FEW compared to that in the general
population (adjusted OR 2.7, 95% CI 1.1, 7.1).

Discussion
This study found that the rate of newly identified HIV
positive cases generated by RTSA was significantly lower
compared to the rate in the traditional walk-in approach.
However, we found that the absolute number of HIV
cases detected during RTSA implementation (RTSA and
walk-in approach combined) was much higher than that
in the six-month period prior to the RTSA implementation and the six-month period after the RTSA implementation ended. This finding indicates that a

Fig. 2 The rate of newly identified HIV positive cases. Abbreviations: RTSA, risk tracing snowball approach

Chhim et al. BMC Infectious Diseases (2017) 17:689
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Fig. 3 Number of newly identified HIV positive cases. Abbreviations: RTSA, risk tracing snowball approach

combination of RTSA and a traditional walk-in approach
may increase new case detection among high-risk populations, especially key populations.
The lower rate of newly identified HIV positive cases
among the RTSA clients than that in the walk-in clients
is not surprising. Individuals who walked in to get tested
are more likely to do so because of their self-perception
of their risky behaviors, or because they felt sick. It is
also plausible that when more individuals are tested, the
HIV rate will naturally go down.
Even though the rate of newly identified HIV positive
cases for the RTSA group was lower than the rate obtained from the clinics’ routine data (walk-in group), this
rate should still be considered acceptable for four reasons. First, the combination of the routine walk-in testing and RTSA during RTSA implementation boosted the
absolute number of HIV new case detection from 32 in
the six-month period prior to the RTSA implementation
to 52 cases in the six-month period of RTSA implementation. Second, CD4 count in RTSA group was higher
than that in the walk-in group. This may infer that
RTSA leads to earlier detection of people living with

Table 4 Recruiters of newly identified HIV positive cases
Recruiters

Recruits
Negative

Positive-newly
identified

Positive-already
aware statusa

Total

Negative

97.5%

1.8%

0.7%

100%
(1532)

Positive-newly
identified

95.7%

0.0%

4.5%

100%
(21)

Positive-already
aware status

94.7%

5.2%

0.0%

100%
(19)

a
All of HIV positive clients who were already aware their HIV positive status
admitted during post-test counselling. The main reason for re-testing was because they wanted to be re-enrolled in pre-ART/ART services after having lost
to follow up at other sites

HIV. Third, the rate of newly identified HIV positive
cases in RTSA group was much higher than the rate of
newly identified HIV positive cases reported nationwide in
programs using an outreach HIV testing approach among
key populations—FEW, MSM, TG women, and PWID–
which has never reached more than 1.0% since the program implementation was started in 2013 [15, 16]. Fourth,
the rate of newly identified HIV positive cases in RTSA
group is comparable to the national HIV prevalence in
each key population: FEW (3.8% vs. 4.6%), MSM (1.7% vs.
2.3%), TG women (2.2% vs. 5.9%), and PWUD (1.7% vs.
4.1%), except PWID (0% vs. 25%) [17–20].
Other than being in a high-risk group (TG women,
MSM) and experiencing tested for HIV, our study did
not find any factors associated with the rate of newly
identified HIV positive cases in either groups—walk-in
and RTSA. The non-significant differences may be explained by the following reasons. First, as with any other
self-reporting measures, risky behaviors may have been
underreported due to social desirability. This was also
observed among the walk-in group by counsellors. Thus,
levels of risks may have been misclassified. In contrast,
the RTSA group may have over-reported their risks to
make their recruiters eligible for financial incentives. It
should be reminded that all recruited individuals can get
HIV testing and receive 2.5 USD transportation compensation regardless their risk status and HIV testing result. However, seeds or recruiters can only get the
incentive when their recruits were screened at risk for
HIV infection. Second, our questionnaire has never been
validated. We may not have asked the right questions to
identify risks. And third, the small sample size may have
contributed to the non-statistically significant associations. Regardless what might be the reasons, using a
risk-screening tool to identify risky clients may have low
validity, especially when it confounded by the use of
monetary incentives. Excluding those who reported low

Chhim et al. BMC Infectious Diseases (2017) 17:689
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Fig. 4 Recruitment graph

risk to HIV infection may also have influenced our ability to further elucidate risk factors.
Theoretically, people are more likely to refer those
who are similar to them [14]. This theory is not necessarily true considering HIV testing results in this
study. HIV negative clients may be happier after getting the test result and might be willing to refer their
peers. In contrast, positive clients were more likely to
stop the recruitment after they learned about their
HIV-positive status. As shown in the network graph,
most of the positive clients did not recruit anyone else to
join the study. This nature has blocked the power of network referral. If HIV-positive clients could recruit more
people, they may recruit their sexual partners and their
peers who had similar risks. However, newly detected
HIV-positive individuals need some time to stabilize their
emotional condition first, or they will never recruit other
people because they do not want others to suspect or
learn about their HIV status.
The strength of this study is the use of well-managed
patients tracking system in Chhouk Sar clinics where the
study was conducted. The online fingerprint system can
track HIV test interval of individual clients. Clients
could not be tested multiple times at one or another
Chhouk Sar clinic within 3 months. However, our study

also has several limitations. First, we could only trace
clients in our system. We could not manage if they were
tested elsewhere. Second, the self-reported risky behaviors may not be reliable due to the use of monetary
incentives. However, identifying sexual risky behaviors
was not the main objective of the study. Rather, it was
the rate of newly identified HIV positive cases that
detected by three-test algorithm —Determine Test,
Stat-Pak, and Uni-Gold [21]. Third, the identification of
newly detected cases was based on counsellors’ skills. In
this sense, we cannot deny the possibility of inclusion of
formerly detected HIV clients in the newly identified
HIV positive group. However, because all newly identified HIV-positive clients were closely followed-up until
they got enrolled in the treatment, only minor discrepancies were likely to happen. Lastly, our study ended up
with inconclusive result whether the RTSA is costeffective because the study design did not allow further
investigation on this important aspect. To address this
shortcoming, cost-effectiveness modelling should be conducted. This kind of study will be able to assess the number of people who will be prevented from HIV infection
resulting from early detection by RTSA, and unit cost to
invest to keep a person uninfected with HIV per year –
known as Disability-Adjusted Life Year (DALY) [22].
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Table 5 Bivariate results of factors associated with HIV infection
Walk-in group
(N = 609)

RTSA group
(N = 1570)

HIV rate OR
(N = 14), (95% CI)
n (%)

HIV rate
OR
(N = 26), n (%) (95% CI)

Table 5 Bivariate results of factors associated with HIV infection
(Continued)

Type of population
FEW

4 (3.6)

4.5 (1.0;20.2)

MSM

10 (3.2)

3.8 (1.0;13.9)*

2 (6.9)

8.7 (1.4;54.6)* 2 (1.5)

1.7 (0.3;10.1)

TG women 5 (8.1)

10.4 (2.4;44.5)* 2 (1.9)

2.2 (0.4;13.4)

PWUD

0 (0.0)

NA

9 (1.5)

1.7 (0.;6.5)

PWID

0 (0.0)

NA

0 (0.0)

NA

General
3 (0.8)
population

Ref.

3 (0.9)

Ref.

Previously tested for HIV
Yes

8 (1.8)

0.5 (0.2;1.4)

17 (1.8)

1.3 (0.6;30)

No

6 (3.6)

Ref.

9 (1.4)

Ref.

Walk-in group
(N = 609)

RTSA group
(N = 1570)

HIV rate OR
(N = 14), (95% CI)
n (%)

HIV rate
OR
(N = 26), n (%) (95% CI)

Injected hormones/any substances to change your appearance (among
TG women only) since last HIV testing or lifetime if never tested for HIV
Yes

1 (9.1)

1.2 (0.1;11.4)

0 (0.0)

NA

No

4 (8.0)

Ref.

2 (2.1)

NA

Been pregnant/had a baby/ had an abortion (among women only)
since last HIV testing or lifetime if never tested for HIV
Yes

0 (0.0)

NA

2 (2.1)

0.6 (0.1;2.6)

No

4 (5.2)

NA

8 (3.7)

Ref.

Abbreviations: OR odds ratio, CI confidence interval, Ref reference group, FEW
female entertainment worker, MSM men who have with men, TG women
transgender women, PWUD people who use drugs, PWID people who inject
drugs; (*) P-value < 0.05

Ever had non-commercial partner since last HIV testing or lifetime if
never tested for HIV
Yes

9 (1.9)

0.5 (0.2;1.6)

21 (1.6)

0.9 (0.4;2.5)

No

5 (3.6)

Ref.

5 (1.8)

Ref.

Sex without a condom with non-commercial partner(s) since last HIV
testing or lifetime if never tested for HIV
Yes

7 (1.6)

0.4 (0.1;1.0)

6 (1.6)

1.1 (0.5;2.7)

No

7 (4.3)

Ref.

20 (1.8)

Ref.

Sex with commercial partner(s) since last HIV testing or lifetime if never
tested for HIV
Yes

7 (3.7)

2.2 (0.8;6.3)

15 (2.1)

1.6 (0.7;3.5)

No

7 (1.7)

Ref.

11 (1.3)

Ref.

Sex without a condom with commercial partner(s) since last HIV testing
or lifetime if never tested for HIV
Yes

5 (4.1)

2.2 (0.7;6.8)

10 (2.4)

1.7(0.8;3.9)

No

9 (1.9)

Ref.

16 (1.4)

Ref.

Had two or more commercial partners per week since last HIV testing or
lifetime if never tested for HIV
Yes

3 (3.2)

1.5 (0.4;5.6)

7 (1.7)

1.0 (0.4;2.4)

No

11 (2.1)

Ref.

19 (1.6)

Ref.

Conclusions
The rate of newly identified HIV positive cases
among the RTSA group was lower than that found
within the walk-in group, but the inclusion of RTSA
method in addition to the traditional walk-in method
boosted new HIV case detection. The higher CD4
counts found in the RTSA group compared to that in
the walk-in group may reveal that RTSA could detect
HIV cases earlier than walk-in approach could do.
Further research is needed to understand whether
RTSA is a cost-effective intervention to prevent ongoing spread of the HIV.

Table 6 Adjusted factors associated with HIV infection
Walk-in group

Experienced STI symptoms since last HIV testing or lifetime if never
tested for HIV
Yes

7 (2.1)

0.8 (0.3;2.3)

12 (2.6)

2.1 (0.9;4.5)

No

7 (2.6)

Ref.

14 (1.3)

Ref.

Ever used drugs since last HIV testing or lifetime if never tested for HIV
Yes
No

2 (3.6)
11 (2.1)

1.7 (0.4;8.1)
Ref.

15 (1.7)
11 (1.7)

1.0 (0.5;2.0)
Ref.

Ever injected drugs since last HIV testing or lifetime if never tested
for HIV
Yes

1 (7.7)

4.0 (0.5;33.0)

0 (0.0)

NA

No

12 (2.1)

Ref.

26 (1.8)

NA

RTSA group

(N = 609)

(N = 1570)

Adjusted OR

Adjusted OR

(95% CI)

(95% CI)

Type of population
FEW

5.2 (0.6;45.2)

5.2 (1.0;28.9)

MSM

10.4 (1.4;77.0)*

2.1 (0.3;14.4)

TG women

15.2 (3.1;75.2)**

2.7 (0.4;17.9)

PWUD

NA

2.3 (0.6;9.2)

PWID

NA

NA

General population

Ref.

Ref.

Yes

0.3 (0.1;0.9)*

1.2 (0.5;2.7)

No

Ref.

Ref.

Previously tested for HIV

Abbreviations: OR odds ratio, CI confidence interval, Ref reference group,
(*) P-value < 0.05, (**) P-value < 0.001
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